2020
DOI: 10.1093/jrr/rraa071
|View full text |Cite
|
Sign up to set email alerts
|

Analyses of local control and survival after stereotactic body radiotherapy for pulmonary oligometastases from colorectal adenocarcinoma

Abstract: This study is a subset analysis of a retrospective multicenter study performed in Japan and its purpose was to investigate the effectiveness of stereotactic body radiotherapy (SBRT) for pulmonary oligometastases from colorectal cancer. Local control (LC), freedom from further metastases, relapse-free survival and overall survival (OS) after SBRT were retrospectively analyzed. The Kaplan–Meier method was used to estimate lifetime data and the log-rank test was performed as univariate analyses. The Cox proportio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 18 publications
0
8
0
Order By: Relevance
“…Stereotactic body radiotherapy (SBRT) is one of the most frequently applied methods of treatment in medically inoperable patients. The efficacy of SBRT in terms of 3-year OS was reported by Agolli [23], Wegner et al [24], and Yamamoto et al [25] at 50.8%, 58%, 63.4% respectively. Relatively lower efficacy of SBRT in these studies is probably associated with radioresistance of colorectal cancer metastases compared to secondary deposits from other tumors -local progression rates are in the range of 42% vs. 16% [8].…”
Section: Oligometastatic Diseasementioning
confidence: 77%
“…Stereotactic body radiotherapy (SBRT) is one of the most frequently applied methods of treatment in medically inoperable patients. The efficacy of SBRT in terms of 3-year OS was reported by Agolli [23], Wegner et al [24], and Yamamoto et al [25] at 50.8%, 58%, 63.4% respectively. Relatively lower efficacy of SBRT in these studies is probably associated with radioresistance of colorectal cancer metastases compared to secondary deposits from other tumors -local progression rates are in the range of 42% vs. 16% [8].…”
Section: Oligometastatic Diseasementioning
confidence: 77%
“…Unfortunately, there is no reliable biomarker for OD and no universally accepted definition [ 10 ]. In most studies, OD was arbitrarily defined as a condition in which there are five metastases or less in imaging studies that are technically treatable with MDT [ 7 ]. In this study, we suggest adding metastases clonal origin to the definition of OD to identify those patients with greatest chance for cure by MDT.…”
Section: Discussionmentioning
confidence: 99%
“…This suggests that SABR provided good palliation, but in most patients produced no cure [ 6 ]. Review of the literature in prostate cancer shows that MDT demonstrates high local control but only a small proportion of the patients remain without progression after 2 years [ 7 ]. When the OD concept was employed in renal cell carcinoma, local results were good with 1-year in-field progression free survival of 70%, but only 39% 1-year out of field progression free survival [ 4 ].…”
Section: Introductionmentioning
confidence: 99%
“…For colorectal pulmonary metastases treated with SABR, reported 2‐, 3‐ and 5‐year local control rates are 75%, 6 60%, 7 and 56%, 8 respectively. These local control rates are lower than those reported for primary lung tumors, 9 and these findings are relevant since local control following SABR correlates with overall survival (OS) 10,11 . In comparison, the 5‐year local control rate after nonanatomical surgical resection for colorectal pulmonary metastases (CRPM) is reported to be 79%–82% 12,13 …”
Section: Introductionmentioning
confidence: 94%
“…These local control rates are lower than those reported for primary lung tumors, 9 and these findings are relevant since local control following SABR correlates with overall survival (OS). 10,11 In comparison, the 5-year local control rate after nonanatomical surgical resection for colorectal pulmonary metastases (CRPM) is reported to be 79%-82%. 12,13 For patients who develop a local recurrence after SABR for pulmonary metastases, treatment options commonly considered include palliative systemic therapy and reirradiation.…”
Section: Introductionmentioning
confidence: 99%